Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Recent advances in mantle cell lymphoma: Expert panel discussion

Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele Zucci
Recent advances in mantle cell lymphoma: Expert panel discussion ( Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele Zucci )
13 May 2014

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany;
Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany; )
12 May 2014

Rituximab versus idelalisib in refractory CLL

Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University  Hospital, Leeds, UK )
9 May 2014

Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients

Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies ( Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg )
6 May 2014

Work and history of the Kidney Cancer Association

Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA
Work and history of the Kidney Cancer Association ( Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA )
6 May 2014

Intratumour heterogeneity in renal and lung cancer

Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK
Intratumour heterogeneity in renal and lung cancer ( Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK )
6 May 2014

Kidney cancer treatment ten years from now

Prof Martin Gore - The Royal Marsden Hospital, London, UK
Kidney cancer treatment ten years from now ( Prof Martin Gore - The Royal Marsden Hospital, London, UK )
6 May 2014

Personalisation of leukaemia treatment using genome sequencing

Dr Giovanni Martinelli - University of Bologna, Bologna, Italy
Personalisation of leukaemia treatment using genome sequencing ( Dr Giovanni Martinelli - University of Bologna, Bologna, Italy )
5 May 2014

High levels of mutated p53 indicate metastatic phenotype

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014